Growth Metrics

BioNexus Gene Lab (BGLC) Change in Cash (2018 - 2025)

BioNexus Gene Lab's Change in Cash history spans 8 years, with the latest figure at $1.1 million for Q4 2025.

  • Quarterly results put Change in Cash at $1.1 million for Q4 2025, up 409.57% from a year ago — trailing twelve months through Dec 2025 was -$400583.0 (up 75.44% YoY), and the annual figure for FY2025 was -$400583.0, up 75.44%.
  • Change in Cash for Q4 2025 was $1.1 million at BioNexus Gene Lab, up from -$180097.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $4.4 million in Q3 2023 to a low of -$1.6 million in Q4 2023.
  • The 5-year median for Change in Cash is -$247064.5 (2022), against an average of -$15065.4.
  • The sharpest move saw Change in Cash skyrocketed 563.89% in 2022, then plummeted 909.32% in 2025.
  • Year by year, Change in Cash stood at $423523.0 in 2021, then tumbled by 257.42% to -$666705.0 in 2022, then crashed by 144.36% to -$1.6 million in 2023, then surged by 113.6% to $221617.0 in 2024, then skyrocketed by 409.57% to $1.1 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $1.1 million, -$180097.0, and -$552249.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.